to March 10, 2026
The 6th annual International Congress on Controversies surrounding Cannabis-based Medicines (MED CANNABIS 2026) is establishing itself as a major event for the scientific and medical community. Organized by Bioevents in Krakow, Poland, the congress brings together world experts to discuss the latest advances in clinical research and therapeutic applications of cannabis. The event offers a privileged platform for debating the controversial issues and challenges currently shaping the cannabinoid medication sector.
The congress is aimed at healthcare professionals (doctors, pharmacists, nurses), researchers and policy-makers, as well as pharmaceutical and biotechnology industry players involved in the development of cannabinoid treatments. The program includes plenary lectures, round tables and presentations of scientific work covering the entire spectrum, from basic research to clinical practice.
This European event reflects the growing recognition of medical cannabis as a legitimate field for therapeutic research and development. For industry professionals, MED CANNABIS 2026 represents an opportunity for scientific updates and strategic networking with decision-makers and innovators in the sector.